Biotech Catalyst Calendar

See the Events That Can Move Biotech Stocks

Track clinical trial readouts, FDA decisions, regulatory milestones and other market-moving biotech events in one research-ready calendar.

Explore the Catalyst Calendar Browse Biotech Companies
Built from source-backed events and organized for investor research.
Q3 2026ARVNPhase 3 data readoutVepdegestrant Phase 3
Verified
Oct 2026CRSPFDA decisionZugocel BLA
Verified
H2 2026MRNAPrimary endpoint resultsmRNA-4157 Phase 3
Verified

Biotech Research Should Not Be a Scavenger Hunt

Potential catalysts are scattered across trial registries, regulatory updates and company disclosures. Fintel brings the dates, drugs, phases and evidence together so you can focus on the events that matter.

Research Biotech Catalysts with More Context

Upcoming Catalyst Calendar

Scan expected clinical, regulatory and corporate milestones by date.

Drug and Trial Context

Connect each event to its drug, indication and clinical development phase.

Company-Level Discovery

Browse public biotech companies and drill into the catalysts attached to each stock.

Focused Screening

Filter by date, event type, phase, status, company or keyword to narrow your research.

Source-Backed Events

Review supporting evidence and verification signals behind published catalyst records.

Upcoming and Historical Data

Put future milestones in context with completed events and prior disclosures.

Turn a Crowded Pipeline into a Clear Research Workflow

Use a structured calendar to move from broad discovery to company-specific due diligence.

  • Find upcoming events across covered biotech stocks in one place.
  • Compare milestones by event type, development phase and timing.
  • Trace catalyst details back to published supporting evidence.
  • Move directly from a catalyst to company and stock-level research.

Start Exploring Biotech Catalysts

Find the clinical and regulatory milestones on the markets calendar.

Open the Catalyst Calendar

Frequently Asked Questions

What is a biotech catalyst?
A biotech catalyst is a clinical, regulatory or corporate milestone that may materially affect how investors value a biotechnology company, such as trial results or an FDA decision.
Which catalyst events does Fintel track?
Fintel tracks clinical trial milestones, data readouts, regulatory submissions and decisions, and other relevant events available for covered public companies.
Can I filter catalysts by company, date or phase?
Yes. The calendar supports search and filters for timing, company, event type, clinical phase, status and verification.
Are catalyst dates guaranteed?
No. Biotech timelines can change, and some dates are estimates or ranges based on public disclosures. Always review the supporting evidence and the latest company or regulatory updates.
Biotech investing involves significant risk. Catalyst dates and outcomes may change without notice. Fintel provides data and research tools for informational purposes only, not personalized investment advice.